GENFIT Announces the Publication of New Data on the Clinical

Lille ; Cambridge ; Zurich ; August 10, 2023 - GENFIT , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, today announced the...
-Today at 04:11 pm- MarketScreener

Related Keywords

Switzerland , Paris , France General , France , Massachusetts , United States , Cambridge , Cambridgeshire , United Kingdom , Arunj Sanyal , Exchange Commission , Uncertainties Of The Company , Older Patients In Hepatology Communications , Nasdaq , Centers For Medicare Medicaid Services , Phepatology Communications , Euronext , Medicaid Services , Non Invasive Test , Primary Biliary Cholangitis , Nasdaq Global Select Market , Private Securities Litigation Reform Act , Registration Document , Receiver Operating , New Data , Clinical Performance , Older Patients , Markets ,